查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2048402

淋巴水腫治療設備市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、地區和競爭格局分類，2021-2031年

Lymphedema Treatment Instrument Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Legs, Arm), By Application (Family, Hospital, Others) By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 177 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球淋巴水腫治療設備市場預計將從 2025 年的 6.2761 億美元成長到 2031 年的 8.5412 億美元，複合年成長率為 5.27%。

該市場涵蓋專用醫療設備和輔助治療產品，例如氣動加壓泵、壓力衣和繃帶系統，旨在促進淋巴引流和控制慢性體液儲存。主要成長要素包括癌症治療導致的次發性淋巴水腫發生率不斷上升，以及易患靜脈和淋巴功能障礙的老年人口不斷成長。例如，根據美國癌症協會統計，到2025年，美國將有約430萬乳癌倖存者，這是一個需要持續進行淋巴水腫管理的重要族群。然而，先進治療技術的高成本，加上不同醫療體系報銷政策的差異，對市場擴張構成了重大挑戰。這往往導致患者無法獲得關鍵的長期治療方案，並阻礙了有效治療設備在成本敏感地區的廣泛應用。

市場概覽
預測期 2027-2031
市場規模：2025年 6.2761億美元
市場規模：2031年 8.5412億美元
複合年成長率：2026-2031年 5.27%
成長最快的細分市場 腿
最大的市場 北美洲

市場促進因素

癌症相關次發性淋巴水腫盛行率的上升是推動市場成長的主要因素。尤其值得注意的是，癌症存活率的提高導致長期淋巴功能障礙患者族群不斷擴大。這使得對專用治療設備的需求持續成長，尤其是在淋巴通路因手術或放射治療而受損的複雜解剖區域。 Tactile Systems Technology 於 2025 年 6 月發布的關鍵統計數據顯示，90% 的頭頸癌倖存者會發展為淋巴水腫，凸顯了對標靶加壓設備的迫切臨床需求。同時，氣動加壓設備的技術進步正在改變治療方式，提高了療效，並證明了居家管理的有效性。生物電電阻光譜和先進氣動演算法的結合，使得淋巴水腫的早期檢測和更精準的液體管理超越了傳統的靜態加壓。臨床檢驗，例如 ImpediMed Limited 於 2025 年 5 月進行的 PREVENT 試驗，顯示生物電電阻技術可將淋巴水腫的進展速度降低 59%。這項技術進步正在直接推動商業性擴張，Tactile Systems Technology 在 2025 年 11 月發布的一份報告證實了這一點，該報告顯示其淋巴水腫產品線的銷售額和租賃額同比成長了 11%。

市場挑戰

全球淋巴水腫治療設備市場面臨的主要障礙是先進治療技術的高昂成本，而醫保報銷政策的不一致更使這個問題雪上加霜。這些經濟障礙導致許多患者無法獲得必要的加壓裝置和專用服裝。當健保覆蓋不足或被拒保時，高額的自付費用使得患者無法獲得併定期更換必要的治療輔助用品，直接降低了製造商的總銷售額，並限制了有效設備在醫療支出有限地區的普及。對於需要長期管理慢性體液滯留的患者而言，這種經濟負擔尤其沉重。淋巴水腫倡導組織在2024年證實，即使是聯邦醫療保險（Medicare）受益人，仍需支付處方壓迫療法裝置核准費用的20%。持續的費用對老年人（淋巴儲存的高風險族群）而言是一項重大挑戰，導致目標族群的接受度降低，並嚴重阻礙了製造商的業務擴張。

市場趨勢

穿戴式和可攜式壓力技術的日益普及，正從根本上改變著病患管理策略，使治療模式從固定的臨床環境轉向行動化、融入日常生活的解決方案。患者越來越需要輕便的設備，以便在嚴格遵守治療方案的同時，也能維持日常活動，這顯著提高了慢性水腫管理的遵從率，並推動了創新製造商的商業性成長。 Tactile Systems Technology公司截至2025年8月的會計年度財務表現顯示，銷售額年增7.8%，這主要得益於其先進的居家淋巴水腫治療方法的廣泛應用。同時，用於壓力服的智慧紡織材料的進步，正在滿足四肢以外複雜解剖區域有效治療的臨床需求。製造商正在開發專用的多腔室壓力服，能夠對腹部和身體軀幹等難以治療的區域施加精確的壓力梯度，從而減少對昂貴客製化產品的依賴。 AIROS Medical 於 2025 年 9 月推出六款新的 8 腔身體軀幹服裝模型，這體現了全面且符合人體解剖學的服裝設計趨勢，也為患者提供了更多接受必要氣動治療的機會。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：淋巴水腫治療設備的全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（腿、手臂）
    • 依用途（家庭、醫院、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美淋巴水腫治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲淋巴水腫治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區淋巴水腫治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲淋巴水腫治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲淋巴水腫治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球淋巴水腫治療設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Tactile Medical
  • Bsn Medical Gmbh
  • 3M Company
  • Cardinal Health Inc.
  • Lohmann & Rauscher Gmbh & Co. Kg
  • Airos Medical, Inc.
  • Avet Pharmaceuticals Inc.
  • Biocompression Systems Inc.
  • Convatec Inc.
  • Herantis Pharma Plc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 16741

The Global Lymphedema Treatment Instrument Market is projected to expand from USD 627.61 million in 2025 to USD 854.12 million by 2031, demonstrating a compound annual growth rate (CAGR) of 5.27%. This market encompasses specialized medical devices and therapeutic aids such as pneumatic compression pumps, compression garments, and bandaging systems, all designed to facilitate lymphatic drainage and manage chronic fluid retention. Key growth drivers include the increasing incidence of secondary lymphedema resulting from cancer treatments and a growing geriatric population prone to venous and lymphatic dysfunctions. For instance, the American Cancer Society reported nearly 4.3 million breast cancer survivors in the United States in 2025, representing a significant demographic in need of ongoing lymphedema management. However, the high cost of advanced treatment technologies, coupled with inconsistent reimbursement policies across various healthcare systems, presents a substantial challenge to market expansion, often limiting patient access to crucial long-term therapeutic solutions and hindering the widespread adoption of effective instrument modalities in cost-sensitive regions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 627.61 Million
Market Size 2031USD 854.12 Million
CAGR 2026-20315.27%
Fastest Growing SegmentLegs
Largest MarketNorth America

Market Driver

The primary catalyst for market demand is the rising prevalence of cancer-related secondary lymphedema, particularly as improvements in oncology survivorship rates lead to an expanding population managing long-term lymphatic dysfunction. This creates an ongoing need for specialized therapeutic instruments, especially for complex anatomical regions where surgical and radiotherapeutic interventions disrupt lymphatic pathways. A significant statistic from Tactile Systems Technology, June 2025, highlighted that 90% of head and neck cancer survivors develop lymphedema, underscoring the urgent clinical demand for targeted compression devices. Concurrently, technological innovations in pneumatic compression devices are transforming treatment by enhancing efficacy and validating home-based management. The integration of bioimpedance spectroscopy and advanced pneumatic algorithms enables earlier detection and more precise fluid management, moving beyond traditional static compression. Clinical validation, such as the ImpediMed Limited PREVENT trial in May 2025, showed a 59% relative reduction in lymphedema progression with bioimpedance technology. This technological advancement directly fuels commercial expansion, evidenced by Tactile Systems Technology's November 2025 report of an 11% year-over-year increase in sales and rentals for their lymphedema product line.

Market Challenge

A significant obstacle to the global lymphedema treatment instrument market is the prohibitive cost associated with advanced treatment technologies, further compounded by inconsistent reimbursement policies. These financial barriers frequently prevent a substantial portion of patients from accessing necessary pneumatic compression devices and specialized garments. When insurance coverage is inadequate or denied, the resulting high out-of-pocket expenses deter patients from acquiring or regularly replacing essential therapeutic aids, directly reducing overall sales volumes for manufacturers and limiting the penetration of effective instruments in regions with constrained healthcare spending. The economic burden is particularly severe for individuals requiring long-term management of chronic fluid retention, as illustrated by the Lymphedema Advocacy Group's 2024 confirmation that Medicare beneficiaries are still responsible for 20 percent of the approved amount for prescribed compression supplies. This recurring expense poses a considerable challenge for the elderly demographic most susceptible to lymphatic dysfunction, thereby creating substantial hurdles for manufacturers in scaling operations due to suppressed adoption rates among the target audience.

Market Trends

The increasing proliferation of wearable and portable compression technologies is fundamentally transforming patient management strategies by enabling a shift from stationary clinical settings to mobile, lifestyle-integrated solutions. Patients are increasingly seeking compact devices that facilitate adherence to rigorous treatment schedules while maintaining daily activities, which significantly improves compliance rates for chronic edema management and drives commercial growth for innovative manufacturers. Tactile Systems Technology's August 2025 financial results, showing a 7.8% year-over-year revenue increase, largely attribute this uptake to the expanded adoption of their advanced, home-based lymphedema therapies. Simultaneously, advancements in smart textile materials for compression garments are addressing the clinical need for effective treatment in complex anatomical areas beyond the extremities. Manufacturers are developing specialized, high-chamber garments capable of delivering precise pressure gradients to difficult regions like the abdomen and trunk, thereby reducing reliance on costly custom-made solutions. This trend towards inclusive and anatomically versatile garment designs, exemplified by AIROS Medical's September 2025 launch of six new 8-chamber truncal garment models, expands patient access to essential pneumatic therapy.

Key Market Players

  • Tactile Medical
  • Bsn Medical Gmbh
  • 3M Company
  • Cardinal Health Inc.
  • Lohmann & Rauscher Gmbh & Co. Kg
  • Airos Medical, Inc.
  • Avet Pharmaceuticals Inc.
  • Biocompression Systems Inc.
  • Convatec Inc.
  • Herantis Pharma Plc

Report Scope

In this report, the Global Lymphedema Treatment Instrument Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lymphedema Treatment Instrument Market, By Type

  • Legs
  • Arm

Lymphedema Treatment Instrument Market, By Application

  • Family
  • Hospital
  • Others

Lymphedema Treatment Instrument Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lymphedema Treatment Instrument Market.

Available Customizations:

Global Lymphedema Treatment Instrument Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Lymphedema Treatment Instrument Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Legs, Arm)
    • 5.2.2. By Application (Family, Hospital, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Lymphedema Treatment Instrument Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Lymphedema Treatment Instrument Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Lymphedema Treatment Instrument Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Lymphedema Treatment Instrument Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Lymphedema Treatment Instrument Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Lymphedema Treatment Instrument Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Lymphedema Treatment Instrument Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Lymphedema Treatment Instrument Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Lymphedema Treatment Instrument Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Lymphedema Treatment Instrument Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Lymphedema Treatment Instrument Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Lymphedema Treatment Instrument Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Lymphedema Treatment Instrument Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Lymphedema Treatment Instrument Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Lymphedema Treatment Instrument Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Lymphedema Treatment Instrument Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Lymphedema Treatment Instrument Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Lymphedema Treatment Instrument Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Lymphedema Treatment Instrument Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Lymphedema Treatment Instrument Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Lymphedema Treatment Instrument Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Lymphedema Treatment Instrument Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Lymphedema Treatment Instrument Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Lymphedema Treatment Instrument Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Lymphedema Treatment Instrument Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Tactile Medical
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Bsn Medical Gmbh
  • 15.3. 3M Company
  • 15.4. Cardinal Health Inc.
  • 15.5. Lohmann & Rauscher Gmbh & Co. Kg
  • 15.6. Airos Medical, Inc.
  • 15.7. Avet Pharmaceuticals Inc.
  • 15.8. Biocompression Systems Inc.
  • 15.9. Convatec Inc.
  • 15.10. Herantis Pharma Plc

16. Strategic Recommendations

17. About Us & Disclaimer